WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,820.00
+20.00 (0.29%)
Dec 27, 2024, 9:00 AM KST
-29.91%
Market Cap 92.94B
Revenue (ttm) 105.74B
Net Income (ttm) 6.73B
Shares Out 13.20M
EPS (ttm) 509.86
PE Ratio 13.81
Forward PE n/a
Dividend n/a
Ex-Dividend Date Dec 27, 2024
Volume 17,521
Open 6,730.00
Previous Close 6,800.00
Day's Range 6,730.00 - 6,860.00
52-Week Range 5,610.00 - 10,230.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2025

About WITHUS PHARMACEUTICAL Co.,LTD.

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name... [Read more]

Industry Pharmaceutical Preparations
Founded 2004
Employees 121
Stock Exchange KOSDAQ
Ticker Symbol 330350
Full Company Profile

Financial Performance

In 2023, WITHUS PHARMACEUTICAL Co.,LTD.'s revenue was 80.12 billion, an increase of 23.87% compared to the previous year's 64.68 billion. Earnings were 7.96 billion, an increase of 221.04%.

Financial Statements

News

There is no news available yet.